Rush scientists are testing whether having a common genetic mutation makes Parkinson’s disease patients more likely to suffer cognitive decline after deep brain stimulation surgery.
The number of cancer clinical trials at Rush doubled last year — from around 30 in early 2015 to nearly 150 by the end of 2016. And the focus of the research has broadened.
Preventive medicine experts at Rush University Medical Center have discovered that delaying access to tempting, high-calorie foods and snacks in vending machines potentially can shift people’s choices to purchase less desired, but healthier snack options. Results of this study will be presented at the Society of Behavioral Medicine’s Annual Meeting & Scientific Sessions being held in San Diego, California.
Physicians at Rush University Medical Center became the first in Illinois to inject AST-OPC1 (oligodendrocyte progenitor cells), an experimental treatment, into the damaged cervical spine of a recently paralyzed man as part of a multicenter clinical trial.
A new clinical study may give hope to stroke victims who reach physicians past the six-hour time window of treatment from the time a stroke occurs.